latest EVENT

Kiji Therapeutics attends ISCT 2024 in Vancouver

Miguel Forte, CEO of Kiji Therapeutics, and Tony Ting, CSO, will attend the ISCT Annual Congress in Vancouver, Canada, May 29-June 1, 2024.

Both have been involved in the organization of the event and will participate as moderators of several sessions throughout the congress.

In addition, on Thursday, May 30th, Dr. Tony Ting will present poster number 188 showing the latest results obtained by Kiji Therapeutics in collaboration with CIEMAT on the efficacy of cryopreserved CXCR4-IL10-MSCs in a xenogeneic model of GvHD.


Kiji Therapeutics will be present at Advanced Therapies Week in Miami, January 16-19, 2024.
Miguel Forte will present Kiji Therapeutics at the Biotech Showcase in San Francisco
Kiji Therapeutics will be present at BioEurope in Munich

why kiji ?

Our name, « Kiji, » meaning « pheasant » in Japanese, is inspired by the Pheasant Island, which alternates sovereignty between Spain and France every six months. Additionally, according to a Japanese legend, a pheasant named Hō-ō was living in the forest when a fire broke out, threatening to destroy the trees and animals. Hō-ō sacrifices itself by flying into the fire to re-born as a majestic phoenix, bringing healing and renewal to the burned forest and its inhabitants. Like Hō-ō, Kiji is committed to the new era, offering hope and renewal to patients with inflammatory conditions.